Alterations in the distribution of apoAII-isoforms are associated with not only IDACP but also other pancreatic disorders, such as endocrine tumors of the pancreas, IPMN, MCN, SCN, and chronic pancreatitis. Here, APOA2 is linked to severe congenital neutropenia.